Rybelsus Tablet
Product Images NDC 0169-4314

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rybelsus (NDC 0169-4314). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk Pharmaceutical Industries, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
Not available.*
FDA Label Image

3mg Bottle (Image 03)

3mg Bottle (Image 03)
RVBELSUS® 3mg is a medication in tablet form containing 3mg of semaglutide. It is intended for oral use only and should be dispensed with a medication guide. Any unreadable text is excluded from this description.*
FDA Label Image

Figure 4 (Image 05)

FDA Label Image

3mg Trade (Image 08)

FDA Label Image

7mg Trade (Image 09)

7mg Trade (Image 09)
RYBELSUS® is a once-daily tablet medication containing semaglutide at a strength of 7mg. It is intended for oral use and is available for prescription only. It is recommended to provide patients with an enclosed medication guide.*
FDA Label Image

14mg Trade (Image 10)

FDA Label Image

7 Bottle (Image 12)

7 Bottle (Image 12)
RVBELSUS® 7mg is a medication in tablet form containing semaglutide. It is intended for oral use only and should be taken once a day. Unfortunately, additional information about this medication is not available due to the limited text provided.*
FDA Label Image

14 Bottle (Image 13)

14 Bottle (Image 13)
RYBELSUS® 14 mg (semaglutide) Tablets are a medication intended for daily use. Unfortunately, the rest of the text is not readable.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.